What sector does Galderma Group N (GALD) operate in?
Galderma Group N belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Galderma Group N (GALD) current stock price?
As of the latest data, Galderma Group N stock price is CHF 153.40, with a previous close of CHF 149.70. Galderma Group N gained CHF 3.70 in the last trading session, representing a 2.47% increase.
What is Galderma Group N (GALD) current market capitalization?
Galderma Group N market cap is approximately 35.98 billion.
What is Galderma Group N (GALD) Earnings Per Share (EPS)?
The trailing EPS is CHF 2.05, and the forward EPS is CHF 6.17.
What is Galderma Group N (GALD) Price-to-Earnings (P/E) ratio?
Galderma Group N current P/E ratio is 74.83, with a forward P/E of 24.86.
What is Galderma Group N (GALD) EBITDA?
Galderma Group N EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 438.27 million.
Does Galderma Group N (GALD) pay dividends?
Yes. Galderma Group N pays annual dividends with an annualized yield of 0.1% and an estimated annual payout of CHF 0.15 per share.
When is the next ex-dividend date for Galderma Group N (GALD)?
The next ex-dividend date is scheduled for April 25, 2026.
When is Galderma Group N (GALD) next earnings report?
Galderma Group N is expected to release its next earnings report on December 31, 2025.
What is Galderma Group N (GALD) beta (volatility) score?
Galderma Group N has a beta of 0.338, indicating lower volatility than the overall market.